Evidence map›Paper›PMID 17028375›Full record

ReviewNeuromolecular medicine2006

Lissencephaly 1 linking to multiple diseases: mental retardation, neurodegeneration, schizophrenia, male sterility, and more.

Orly Reiner, Sivan Sapoznik, Tamar Sapir

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neuromolecular medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. IQGAP1 regulates NR2A signaling, spine density, and cognitive processes.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Cytoskeleton in action: lissencephaly, a neuronal migration disorder.Wiley interdisciplinary reviews. Developmental biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Orly ReinerDepartment of Molecular Genetics, The Weizmann Institute of Science, 76100 Rehovot, Israel. orly.reiner@weizmann.ac.il
Sivan Sapoznik
Tamar Sapir
Weizmann Institute of Science · IL

Funding

Fine-tuning of LIS1-Nudel InteractionsR03TW007048 · FIC · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI TSAI, LI-HUEI · 2004 to 2006
$102k
FIC NIH HHS R03TW007048
6 · The paper itself

Abstract

Lissencephaly 1 (LIS1) was the first gene implicated in the pathogenesis of type-1 lissencephaly. More than a decade of research by multiple laboratories has revealed that LIS1 is a key node protein, which participates in several pathways, including association with the molecular motor cytoplasmic dynein, the reelin signaling pathway, and the platelet-activating factor pathway. Mutations in LIS1-interacting proteins, either in human, or in mouse models has suggested that LIS1 might play a role in the pathogenesis of numerous diseases such as male sterility, schizophrenia, neuronal degeneration, and viral infections.

Indexed as

1-Alkyl-2-acetylglycerophosphocholine EsteraseAnimalsCentral Nervous System Viral DiseasesClassical Lissencephalies and Subcortical Band HeterotopiasHumansInfertility, MaleIntellectual DisabilityMaleMiceMicrotubule-Associated ProteinsMutationNerve DegenerationProtein BindingReelin ProteinSchizophreniaSignal Transduction1-Alkyl-2-acetylglycerophosphocholine EsteraseMicrotubule-Associated ProteinsPAFAH1B1 protein, humanPafah1b1 protein, mouseReelin ProteinRELN protein, humanReln protein, mouse

Identifiers

PMID17028375
OpenAlexW2034066693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.